Radiopharmaceuticals Market 2018 Industry Share, Growth, Size, Trend, World Analysis and Forecast to 2023

The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period. The market is right now in its development phase driven by expanding number of disease cases and increasing awareness about nuclear medication. Radiopharmaceuticals are pharmaceutical formulations involving radioactive isotopes that are useful as a part of analysis and therapeutics. They are basic and small substances that contain a radioactive substance that is useful as a part of the treatment of cancer and neurological and cardiac disorders. The regular chemotherapy techniques are being supplanted by more advantageous helpful radiopharmaceuticals for oncology and cancer treatment, which opens up new roads in the radiopharmaceuticals market.

Access sample copy of this report https://www.crystalmarketresearch.com/report-sample/HC01517

Radiopharmaceuticals market: Regional Outlook
Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World.  North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others.

Radiopharmaceuticals market: Competitive Insights
The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt.

Radiopharmaceuticals market By Type

  • Diagnostic Nuclear Medicine/Radiopharmaceuticals
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Nuclear Medicine/Radiopharmaceuticals
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy

Radiopharmaceuticals market By Procedural Volumes

  • Diagnostic Procedures
  • SPECT Radiopharmaceuticals
  • PET Radiopharmaceuticals
  • Therapeutic Procedures
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy

Browse Full Report With TOC @ https://www.crystalmarketresearch.com/report/radiopharmaceuticals-market

Table of Contents:

  1. Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

  1. Executive Summary

2.1.       Key Highlights

  1. Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Alpha Radioimmunotherapy (Rit)-Based Targeted Cancer Treatment

3.2.1.2.    Increasing Incidence and Prevalence of Cancer and Cardiac Ailments

3.2.2.  Restraints

3.2.2.1.    High Cost of Nuclear Medicine Equipment

3.2.2.2.    Shorter Half-Life of Radiopharmaceuticals

3.2.3.  Opportunities

3.2.3.1.    Emerging Countries to Offer Lucrative Growth Opportunities

3.2.3.2.    Use of Radiopharmaceuticals in Neurological Applications

  1. Radiopharmaceuticals Market, By Type

4.1.       Introduction

4.2.       Global Radiopharmaceuticals Sales, Revenue and Market Share by Type (2014-2017)

4.2.1.  Global Radiopharmaceuticals Sales and Sales Share by Type (2014-2017)

4.2.2.  Global Radiopharmaceuticals Revenue and Revenue Share by Type (2014-2017)

4.3.       Radiopharmaceuticals Market   Assessment and Forecast, By Type, 2014-2023

4.4.       Diagnostic Radiopharmaceuticals

4.4.1.  Market Assessment and Forecast, By Type, 2014-2023($Billion)

4.4.2.  Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.4.3.  SPECT Radiopharmaceuticals

4.4.3.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

4.4.4.  PET Radiopharmaceuticals

4.4.4.1.    Market Assessment and Forecast, By Region, 2014-2023($Billion)

…CONTINUED FOR TOC

To avail discount, please click on the link @ https://www.crystalmarketresearch.com/check-discount/HC01517

About Crystal Market Research: 
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact: 
Crystal Market Research
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

%d bloggers like this: